CoQ10/LDL-C levels at 6 months were increased in the rosuvastatin group ( +23.5 % , p < 0.01 ) and percent changes in CoQ10/LDL-C were correlated with the myocardial salvage index ( r = 0.56 , p < 0.01 ) .